Cutting through complexity: the promise of biomarkers to discover, diagnose, and treat antibody-associated demyelination

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1141169

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Patients with damage to myelin, the sheath around nerve cells in the brain, have “demyelinating disorders” which can result in severe disability including blindness and paralysis. In some patients, their immune system mistakenly targets certain proteins in the brain. This research project will identify new targets in currently undiagnosed patients, increase our understanding of underlying disease processes, and evaluate optimal treatment strategies in these patients to improve their outcomes.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2022

Funding Scheme: Early Career Fellowships

Funding Amount: $438,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Central Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antibody | demyelination | immunotherapy | myelin | optic neuritis

Related Links